HDP-201

N/A

Report date: 2024/10/28 11:05:16

Base Information

Drug NameHDP-201

Drug Alias NameHDP-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Amanitin payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitorsGuanylate cyclase modulators

TargetsBacterial DNA-directed RNA polymeraseGuanylate cyclase

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHeidelberg Pharma AG

China Registration ClassN/A

Develop Information

Active CompaniesHeidelberg Pharma AG

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A